Sunday, August 1, 2021

Indian Immunologicals to start drug substance production for Covaxin from June

Hyderabad: Indian Immunologicals Ltd, a city-based facility under the National Dairy Development Board, has announced its plans to begin the production of drug substance meant for COVID-19 vaccine Covaxin from June 15, and despatch the first batch to Bharat Biotech by July.

IILs Managing Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million doses per month.

It will be scaled up to 7 million later in the year and eventually to 15 million.

To further increase the COVID-19 vaccine manufacturing capacity, Bharat Biotech had said it partnered with IIL to make the drug substance for Covaxin.

The technology transfer process was well underway and IIL has the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment, the drug had said.

Kumar said IIL is converting its Karkapatla manufacturing unit near here into a Biosafety Level -3 (BSL3) facility for the production of the drug substance and also taking up construction of another block.

IIL is also working on another COVID -19 vaccine and the animal trials are underway and is expected to come out next year for human vaccination, he noted.

Source: https://health.economictimes.indiatimes.com/

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...